News of Note—Recro and Novartis extend pact

Woman typing on computer
Pacira Pharmaceuticals says that CMDO Thermo Fisher Scientific Pharma Services has started commercial production of its a surgical pain drug Exparel. (Max Pixel CC0)

> Recro Pharma has entered into a five-year manufacturing and supply agreement with Novartis to continue to be the exclusive global supplier of Ritalin LA and Focalin XR capsules through 2023. Release

> Pacira Pharmaceuticals says that CMDO Thermo Fisher Scientific Pharma Services has started commercial production of its a surgical pain drug Exparel at a facility in the U.K. that is expected to double the company’s manufacturing capacity. Release

> Women’s health focused Mithra says it has successfully produced its first commercial batch of vaginal contraceptive Myring for the European market. Release (PDF)

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

 

Suggested Articles

As a key global ingredient supplier, problems in China can ripple worldwide as they have for Swiss CDMO Lonza.

What challenges continue to plague the pharmaceutical industry for almost a decade? Check out this remarkable innovation in glass science that may be the…

WuXi Biologics says its plant in Wuxi, China, has gotten the go-ahead from the FDA to make HIV drug Trogarzo for TaiMed Biologics.